This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Beth Israel Deaconess Medical Center, Inc., The General Hospital Corporation. Active years: 2016-2019.
Company Filing History:
3 out of 536 
1 out of 3,067 
Years Active: 2016-2019
Title: Alan C Rigby: Innovator in Cardiovascular Treatment
Introduction
Alan C Rigby is a notable inventor based in Newton, MA, who has made significant contributions to the field of cardiovascular medicine. With a total of three patents to his name, Rigby's work focuses on innovative treatments for heart conditions through the inhibition of SGK1.
Latest Patents
Rigby's latest patents revolve around the inhibition of SGK1 in the treatment of both acquired and genetic heart conditions. This includes conditions such as Long QT syndrome and various cardiovascular diseases, including dilated cardiomyopathy. The patents detail methods for treating cardiovascular diseases that are responsive to SGK1 inhibition, which encompasses heart failure, arrhythmia, ischemic injury, ischemic infarction, cardiac fibrosis, vascular proliferation, restenosis, and stent failure. Furthermore, the inventions identify selective inhibitors of SGK1 and describe the administration of therapeutically effective amounts of these inhibitors to subjects.
Career Highlights
Throughout his career, Alan C Rigby has worked with esteemed institutions such as Beth Israel Deaconess Medical Center and The General Hospital Corporation. His experience in these organizations has allowed him to develop and refine his innovative approaches to treating heart conditions.
Collaborations
Rigby has collaborated with notable colleagues, including Anthony Rosenzweig and Saumya Das, contributing to the advancement of cardiovascular research and treatment methodologies.
Conclusion
Alan C Rigby stands out as a pioneering inventor in the realm of cardiovascular treatment, with his innovative patents aimed at improving the lives of those suffering from heart conditions. His work continues to influence the medical field and offers hope for effective treatments.